^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Nerofe (84AA-API 14AA)

    i
    Associations
    News

    Trials

    Company:
    Immune System Key
    Drug class:
    Apoptosis stimulant, Angiogenesis inhibitor, ST2 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors (NCT05661201)
    Phase 1
    Georgetown University
    Recruiting
    Last update posted :
    03/11/2024
    Initiation :
    04/12/2023
    Primary completion :
    01/01/2026
    Completion :
    01/01/2026
    KRAS • ST2
    |
    KRAS mutation
    |
    doxorubicin hydrochloride • Nerofe (84AA-API 14AA)
    Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML (NCT04365179)
    Phase 1b
    Immune System Key Ltd
    Recruiting
    Last update posted :
    07/22/2022
    Initiation :
    06/18/2020
    Primary completion :
    12/30/2022
    Completion :
    12/30/2022
    ST2
    |
    Nerofe (84AA-API 14AA)
    Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer (NCT03634150)
    Phase 1b
    Immune System Key Ltd
    Withdrawn
    Last update posted :
    10/26/2021
    Initiation :
    09/06/2018
    Primary completion :
    04/21/2020
    Completion :
    04/21/2020
    ST2
    |
    doxorubicin hydrochloride • Nerofe (84AA-API 14AA)
    A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS (NCT03059615)
    Phase 2a
    Immune System Key Ltd
    Withdrawn
    Last update posted :
    07/31/2020
    Initiation :
    10/25/2018
    Primary completion :
    07/26/2020
    Completion :
    07/26/2020
    ST2
    |
    doxorubicin hydrochloride • Nerofe (84AA-API 14AA)
    Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies (NCT01690741)
    Phase 1
    Immune System Key Ltd
    Completed
    Last update posted :
    06/25/2018
    Initiation :
    12/01/2013
    Primary completion :
    12/19/2017
    Completion :
    12/19/2017
    ST2
    |
    Nerofe (84AA-API 14AA)